Phenotypical Characteristics of Chemically Induced Mammary Tumor
- Authors: Kabakov A.V.1, Lykov A.P.1, Morozov D.V.1, Kazakov O.V.1, Poveshchenko A.F.1, Raiter T.V.1, Strunkin D.N.1, Konenkov V.I.1
- 
							Affiliations: 
							- Research Institute of Clinical and Experimental Lymphology
 
- Issue: Vol 163, No 4 (2017)
- Pages: 490-492
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239024
- DOI: https://doi.org/10.1007/s10517-017-3835-6
- ID: 239024
Cite item
Abstract
The histological and immunohistochemical type of chemically induced (injection of N-methyl-N-nitrosourea into the mammary gland) breast tumor was studied in Wistar females. The tumor induced by N-methyl-N-nitrosourea was moderately differentiated adenocarcinoma with infiltrative growth lacking estrogen-α and human epidermal growth factor receptors, and expressing progesterone receptors; tumor cells were characterized by high proliferative activity. This variant of chemically induced breast tumor corresponds to human breast cancer luminal type B.
About the authors
A. V. Kabakov
Research Institute of Clinical and Experimental Lymphology
							Author for correspondence.
							Email: doctor03-85@ngs.ru
				                					                																			                												                	Russian Federation, 							Novosibirsk						
A. P. Lykov
Research Institute of Clinical and Experimental Lymphology
														Email: doctor03-85@ngs.ru
				                					                																			                												                	Russian Federation, 							Novosibirsk						
D. V. Morozov
Research Institute of Clinical and Experimental Lymphology
														Email: doctor03-85@ngs.ru
				                					                																			                												                	Russian Federation, 							Novosibirsk						
O. V. Kazakov
Research Institute of Clinical and Experimental Lymphology
														Email: doctor03-85@ngs.ru
				                					                																			                												                	Russian Federation, 							Novosibirsk						
A. F. Poveshchenko
Research Institute of Clinical and Experimental Lymphology
														Email: doctor03-85@ngs.ru
				                					                																			                												                	Russian Federation, 							Novosibirsk						
T. V. Raiter
Research Institute of Clinical and Experimental Lymphology
														Email: doctor03-85@ngs.ru
				                					                																			                												                	Russian Federation, 							Novosibirsk						
D. N. Strunkin
Research Institute of Clinical and Experimental Lymphology
														Email: doctor03-85@ngs.ru
				                					                																			                												                	Russian Federation, 							Novosibirsk						
V. I. Konenkov
Research Institute of Clinical and Experimental Lymphology
														Email: doctor03-85@ngs.ru
				                					                																			                												                	Russian Federation, 							Novosibirsk						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					